Skip to main content
Top
Published in: Journal of Gastroenterology 2/2018

01-02-2018 | Original Article—Alimentary Tract

Celiac disease in non-clinical populations of Japan

Authors: Mai Fukunaga, Norihisa Ishimura, Chika Fukuyama, Daisuke Izumi, Nahoko Ishikawa, Asuka Araki, Akihiko Oka, Tomoko Mishiro, Shunji Ishihara, Riruke Maruyama, Kyoichi Adachi, Yoshikazu Kinoshita

Published in: Journal of Gastroenterology | Issue 2/2018

Login to get access

Abstract

Background

Celiac disease is a chronic autoimmune enteropathy caused by gluten ingestion. While its prevalence in Western countries is reported to be as high as 1%, the prevalence has not been evaluated in a large-scale study of a Japanese population. The aim of our study was to clarify the possible presence of celiac disease in a Japanese non-clinical population as well as in patients showing symptoms suggestive of the disease.

Methods

Serum samples were collected from 2008 non-clinical adults and 47 patients with chronic unexplained abdominal symptoms between April 2014 and June 2016. The anti-tissue transglutaminase (TTG) immunoglobulin A antibody titer was determined as a screening test for celiac disease in all subjects, and individuals with a value of >2 U/mL subsequently underwent testing for the presence of serum endomysial IgA antibody (EMA) as confirmation. Those testing positive for EMA or with a high concentration (>10 U/mL) of TTG were further investigated by histopathological examinations of duodenal mucosal biopsy specimens and HLA typing tests.

Results

Of the 2008 non-clinical adults from whom serum samples were collected, 161 tested positive for TTG, and all tested negative for EMA. Four subjects who had a high TTG titer were invited to undergo confirmatory testing, and the histopathological results confirmed the presence of celiac disease in only a single case (0.05%). Of the 47 symptomatic patients, one (2.1%) was found to have a high TTG titer and was diagnosed with celiac disease based on duodenal histopathological findings.

Conclusion

The presence of celiac disease in a non-clinical Japanese population was low at 0.05% and was rarely found in patients with unexplained chronic abdominal symptoms.
Literature
1.
go back to reference Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.CrossRefPubMedPubMedCentral Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210–28.CrossRefPubMedPubMedCentral
2.
4.
go back to reference Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009;169:651–8.CrossRefPubMed Ford AC, Chey WD, Talley NJ, et al. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009;169:651–8.CrossRefPubMed
5.
go back to reference Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol. 2012;34:473–8.CrossRefPubMed Reilly NR, Green PH. Epidemiology and clinical presentations of celiac disease. Semin Immunopathol. 2012;34:473–8.CrossRefPubMed
6.
go back to reference van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46.CrossRefPubMed van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010;303:1738–46.CrossRefPubMed
7.
go back to reference Oxentenko AS, Murray JA. Celiac disease: ten things that every gastroenterologist should know. Clin Gastroenterol Hepatol. 2015;13:1396–404.CrossRefPubMed Oxentenko AS, Murray JA. Celiac disease: ten things that every gastroenterologist should know. Clin Gastroenterol Hepatol. 2015;13:1396–404.CrossRefPubMed
8.
9.
go back to reference Vives-Pi M, Takasawa S, Pujol-Autonell I, et al. Biomarkers for diagnosis and monitoring of celiac disease. J Clin Gastroenterol. 2013;47:308–13.CrossRefPubMed Vives-Pi M, Takasawa S, Pujol-Autonell I, et al. Biomarkers for diagnosis and monitoring of celiac disease. J Clin Gastroenterol. 2013;47:308–13.CrossRefPubMed
10.
go back to reference Fernandez E, Riestra S, Rodrigo L, et al. Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population. World J Gastroenterol. 2005;11:3762–6.CrossRefPubMedPubMedCentral Fernandez E, Riestra S, Rodrigo L, et al. Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population. World J Gastroenterol. 2005;11:3762–6.CrossRefPubMedPubMedCentral
11.
go back to reference Srinivas M, Basumani P, Podmore G, et al. Utility of testing patients, on presentation, for serologic features of celiac disease. Clin Gastroenterol Hepatol. 2014;12:946–52.CrossRefPubMed Srinivas M, Basumani P, Podmore G, et al. Utility of testing patients, on presentation, for serologic features of celiac disease. Clin Gastroenterol Hepatol. 2014;12:946–52.CrossRefPubMed
12.
go back to reference Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology. 2005;128:S33–7.CrossRefPubMed Liu E, Rewers M, Eisenbarth GS. Genetic testing: who should do the testing and what is the role of genetic testing in the setting of celiac disease? Gastroenterology. 2005;128:S33–7.CrossRefPubMed
13.
go back to reference Kang JY, Kang AH, Green A, et al. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45.CrossRefPubMed Kang JY, Kang AH, Green A, et al. Systematic review: worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther. 2013;38:226–45.CrossRefPubMed
14.
go back to reference Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology. 2005;128:S47–51.CrossRefPubMed Rewers M. Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology. 2005;128:S47–51.CrossRefPubMed
15.
go back to reference West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109:757–68.CrossRefPubMedPubMedCentral West J, Fleming KM, Tata LJ, et al. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am J Gastroenterol. 2014;109:757–68.CrossRefPubMedPubMedCentral
16.
go back to reference Hall EH, Crowe SE. Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment. Dig Dis. 2011;29:249–54.CrossRefPubMed Hall EH, Crowe SE. Environmental and lifestyle influences on disorders of the large and small intestine: implications for treatment. Dig Dis. 2011;29:249–54.CrossRefPubMed
17.
go back to reference Ihara M, Makino F, Sawada H, et al. Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. Intern Med. 2006;45:135–40.CrossRefPubMed Ihara M, Makino F, Sawada H, et al. Gluten sensitivity in Japanese patients with adult-onset cerebellar ataxia. Intern Med. 2006;45:135–40.CrossRefPubMed
18.
go back to reference Ohata C, Ishii N, Hamada T, et al. Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years. Clin Dev Immunol. 2012;2012:562168.CrossRefPubMedPubMedCentral Ohata C, Ishii N, Hamada T, et al. Distinct characteristics in Japanese dermatitis herpetiformis: a review of all 91 Japanese patients over the last 35 years. Clin Dev Immunol. 2012;2012:562168.CrossRefPubMedPubMedCentral
19.
go back to reference Watanabe C, Komoto S, Hokari R, et al. Prevalence of serum celiac antibody in patients with IBD in Japan. J Gastroenterol. 2014;49:825–34.CrossRefPubMed Watanabe C, Komoto S, Hokari R, et al. Prevalence of serum celiac antibody in patients with IBD in Japan. J Gastroenterol. 2014;49:825–34.CrossRefPubMed
20.
go back to reference Katanoda K, Matsumura Y. National nutrition survey in Japan–its methodological transition and current findings. J Nutr Sci Vitaminol (Tokyo). 2002;48:423–32.CrossRef Katanoda K, Matsumura Y. National nutrition survey in Japan–its methodological transition and current findings. J Nutr Sci Vitaminol (Tokyo). 2002;48:423–32.CrossRef
23.
go back to reference Bonatto MW, Kotze L, Orlandoski M, et al. Endoscopic evaluation of celiac disease severity and its correlation with histopathological aspects of the duodenal mucosa. Endosc Int Open. 2016;4:E767–77.CrossRefPubMedPubMedCentral Bonatto MW, Kotze L, Orlandoski M, et al. Endoscopic evaluation of celiac disease severity and its correlation with histopathological aspects of the duodenal mucosa. Endosc Int Open. 2016;4:E767–77.CrossRefPubMedPubMedCentral
24.
go back to reference Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–54.CrossRefPubMed Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102:330–54.CrossRefPubMed
25.
go back to reference Villanacci V, Ceppa P, Tavani E, et al. Coeliac disease: the histology report. Dig Liver Dis. 2011;43[Suppl 4]:S385–95.CrossRefPubMed Villanacci V, Ceppa P, Tavani E, et al. Coeliac disease: the histology report. Dig Liver Dis. 2011;43[Suppl 4]:S385–95.CrossRefPubMed
26.
go back to reference Muniz JG, Sdepanian VL, Fagundes UN. Prevalence of genetic susceptibility for celiac disease in blood donors in Sao Paulo. Brazil Arq Gastroenterol. 2016;53:267–72.CrossRefPubMed Muniz JG, Sdepanian VL, Fagundes UN. Prevalence of genetic susceptibility for celiac disease in blood donors in Sao Paulo. Brazil Arq Gastroenterol. 2016;53:267–72.CrossRefPubMed
27.
go back to reference Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.CrossRefPubMed Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology. 2006;131:1981–2002.CrossRefPubMed
28.
go back to reference Saito S, Ota S, Yamada E, et al. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 2000;56:522–9.CrossRefPubMed Saito S, Ota S, Yamada E, et al. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens. 2000;56:522–9.CrossRefPubMed
29.
go back to reference Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017;112:65–76.CrossRefPubMed Irvine AJ, Chey WD, Ford AC. Screening for celiac disease in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2017;112:65–76.CrossRefPubMed
30.
go back to reference Petrarca L, Nenna R, Mastrogiorgio G, et al. Dyspepsia and celiac disease: prevalence, diagnostic tools and therapy. World J Methodol. 2014;4:189–96.CrossRefPubMedPubMedCentral Petrarca L, Nenna R, Mastrogiorgio G, et al. Dyspepsia and celiac disease: prevalence, diagnostic tools and therapy. World J Methodol. 2014;4:189–96.CrossRefPubMedPubMedCentral
31.
go back to reference Sanchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M, et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case–control study. Neurogastroenterol Motil. 2016;28:994–1000.CrossRefPubMed Sanchez-Vargas LA, Thomas-Dupont P, Torres-Aguilera M, et al. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case–control study. Neurogastroenterol Motil. 2016;28:994–1000.CrossRefPubMed
32.
go back to reference Di Tola M, Marino M, Goetze S, et al. Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study. J Gastroenterol. 2016;51:1031–9.CrossRefPubMed Di Tola M, Marino M, Goetze S, et al. Identification of a serum transglutaminase threshold value for the noninvasive diagnosis of symptomatic adult celiac disease patients: a retrospective study. J Gastroenterol. 2016;51:1031–9.CrossRefPubMed
33.
go back to reference Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ. 2007;335:1244–7.CrossRefPubMedPubMedCentral Korponay-Szabo IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ. 2007;335:1244–7.CrossRefPubMedPubMedCentral
34.
go back to reference Hill P, Austin A, Forsyth J, et al. British Society of Gastroenterology guidelines on the diagnosis and management of coeliac disease. Gut. 2015;64:691–2.CrossRefPubMed Hill P, Austin A, Forsyth J, et al. British Society of Gastroenterology guidelines on the diagnosis and management of coeliac disease. Gut. 2015;64:691–2.CrossRefPubMed
35.
go back to reference Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147:294–302.CrossRefPubMed Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147:294–302.CrossRefPubMed
36.
go back to reference Kim CY, Quarsten H, Bergseng E, et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA. 2004;101:4175–9.CrossRefPubMedPubMedCentral Kim CY, Quarsten H, Bergseng E, et al. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA. 2004;101:4175–9.CrossRefPubMedPubMedCentral
37.
go back to reference Lundin KE, Gjertsen HA, Scott H, et al. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994;41:24–7.CrossRefPubMed Lundin KE, Gjertsen HA, Scott H, et al. Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. Hum Immunol. 1994;41:24–7.CrossRefPubMed
38.
go back to reference Paulsen G, Lundin KE, Gjertsen HA, et al. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. Hum Immunol. 1995;42:145–53.CrossRefPubMed Paulsen G, Lundin KE, Gjertsen HA, et al. HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. Hum Immunol. 1995;42:145–53.CrossRefPubMed
39.
go back to reference Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol. 2008;103:997–1003.CrossRefPubMed Megiorni F, Mora B, Bonamico M, et al. HLA-DQ and susceptibility to celiac disease: evidence for gender differences and parent-of-origin effects. Am J Gastroenterol. 2008;103:997–1003.CrossRefPubMed
Metadata
Title
Celiac disease in non-clinical populations of Japan
Authors
Mai Fukunaga
Norihisa Ishimura
Chika Fukuyama
Daisuke Izumi
Nahoko Ishikawa
Asuka Araki
Akihiko Oka
Tomoko Mishiro
Shunji Ishihara
Riruke Maruyama
Kyoichi Adachi
Yoshikazu Kinoshita
Publication date
01-02-2018
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 2/2018
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-017-1339-9

Other articles of this Issue 2/2018

Journal of Gastroenterology 2/2018 Go to the issue

Original Article—Liver, Pancreas, and Biliary Tract

Response criteria of tolvaptan for the treatment of hepatic edema